Cargando…
Efficient and tumor-specific knockdown of MTDH gene attenuates paclitaxel resistance of breast cancer cells both in vivo and in vitro
BACKGROUND: Drug resistance of paclitaxel (TAX), the first-line chemotherapy drug for breast cancer, was reported to develop in 90% of patients with breast cancer, especially metastatic breast cancer. Investigating the mechanism of TAX resistance of breast cancer cells and developing the strategy im...
Autores principales: | Yang, Liu, Tian, Yanhua, Leong, Wei Sun, Song, Heng, Yang, Wei, Wang, Meiqi, Wang, Xinle, Kong, Jing, Shan, Baoen, Song, Zhengchuan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6145322/ https://www.ncbi.nlm.nih.gov/pubmed/30227879 http://dx.doi.org/10.1186/s13058-018-1042-7 |
Ejemplares similares
-
Molecular Modification of Metadherin/MTDH Impacts the Sensitivity of Breast Cancer to Doxorubicin
por: Song, Zhenchuan, et al.
Publicado: (2015) -
Knockdown MTDH Inhibits Glioma Proliferation and Migration and Promotes Apoptosis by Downregulating MYBL2
por: Fu, Junqi, et al.
Publicado: (2022) -
Elevated expression of MTDH predicts better prognosis of locally advanced HER-2 positive breast cancer patients receiving neoadjuvant chemotherapy plus trastuzumab
por: Wang, Xinle, et al.
Publicado: (2019) -
The MTDH (−470G>A) Polymorphism Is Associated with Ovarian Cancer Susceptibility
por: Yuan, Cunzhong, et al.
Publicado: (2012) -
MTDH is an oncogene in multiple myeloma, which is suppressed by Bortezomib treatment
por: Gu, Chunyan, et al.
Publicado: (2015)